Low-Dose Adjuvant Aspirin Decreases Incidence of Recurrence Among Patients with Resected PI3K-Altered CRC By Ogkologos - September 30, 2025 110 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the ALASCCA study Source RELATED ARTICLESMORE FROM AUTHOR The Legacy of the ESMO Patient Engagement Summit 2025: Advancing Rights of Patients with Cancer via Cross-Border Best Practices and Collaboration Sustained PFS Benefit of Imlunestrant Over SoC in Patients with ESR1-mutated Advanced Breast Cancer ESMO Welcomes Launch of Health Package Introducing EU Measures That Can Boost Innovation in Oncology and Help Prevent New Cancer Cases MOST POPULAR ESMO Welcomes EU Proposals for MFF & FP10 and Calls for... July 21, 2025 Radiotherapy Can Be Safely Omitted in Older Women with Low-Risk, HR-positive... February 24, 2023 Perguntas frequentes sobre COVID-19 e câncer: respostas para pacientes e sobreviventes June 23, 2020 EMA Recommends Granting a Marketing Authorisation for Lutetium (177Lu) Vipivotide Tetraxetan October 19, 2022 Load more HOT NEWS Experimental mRNA Vaccine Hints at Potential Against Glioblastoma News digest – targeted ‘lava lamp’ treatment, skin cancer biopsies and... Colposcopia: Cómo prepararse y qué saber How To Respond When Your Parents Are Critical Of Your Parenting...
